Ensuring timely antibody delivery in the face of supply chain challenges - contact us for solutions

Rat Anti-Human IL-3-UNLB (BVD3-1F9)

Cat. No.:
Purified Anti-Human IL-3 antibody for use in flow cytometry, immunohistochemistry, ELISA, western blot, and immunoprecipitation assays.
Size Price (USD) Quantity
0.5 mg $253.00
More Information
Clone BVD3-1F9
Isotype Rat IgG1κ
Isotype Control Rat IgG1-UNLB (KLH/G1-2-2)
Specificity Human IL-3
Alternative Names Interleukin-3, burst promoting activity, BP/BPA, eosinophil colony stimulating factor, Eo-CSF, hematopoietic cell growth factor, HCGF, mast cell growth factor, MGF, MCGF, multi-colony stimulating factor, multi-CSF, P cell stimulating activity, PCSA
Immunogen Yeast-expressed human IL-3
Conjugate UNLB (Unconjugated)
Buffer Formulation Borate buffered saline, pH 8.2
Clonality Monoclonal
Concentration 0.5 mg/mL
Volume 1.0 mL
Recommended Storage 2-8°C
Applications ELISA-Detection – Quality tested 1-4
Flow Cytometry – Reported in literature 5,6
Immunohistochemistry-Frozen Sections – Reported in literature 7,8
Western Blot – Reported in literature 1
Immunoprecipitation – Reported in literature 1,2

Note – May be paired with the purified clone BVD8-3G11 (SB Cat. No. 10115-01) in a sandwich ELISA

RRID Number AB_2794147
Gene ID 3562 (Human)
Gene ID Symbol IL3 (Human)
Gene ID Aliases IL-3; MCGF; MULTI-CSF
UniProt ID P08700 (Human
UniProt Name IL3_HUMAN (Human)

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?
or call 800.722.2255
  1. 1. Kaushansky K, Shoemaker SG, Broudy VC, Lin NL, Matous JV, Alderman EM, et al. Structure-function relationships of interleukin-3. An analysis based on the function and binding characteristics of a series of interspecies chimera of gibbon and murine interleukin-3. J Clin Invest. 1992;90:1879-88. (Immunogen, ELISA-Detection, WB, IP)
  2. 2. Abrams JS, Roncarolo M, Yssel H, Andersson U, Gleich GJ, Silver JE. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev. 1992;127:5-24. (ELISA-Detection, IP)
  3. 3. Mahanty S, Abrams JS, King CL, Limaye AP, Nutman TB. Parallel regulation of IL-4 and IL-5 in human helminth infections. J Immunol. 1992;148:3567-71. (ELISA-Detection)
  4. 4. Abrams JS. Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies. Curr Protoc Immunol. 2001;6.20:1-15. (ELISA-Detection)
  5. 5. Giuliani N, Morandi F, Tagliaferri S, Colla S, Bonomini S, Sammarelli G, et al. Interleukin-3 (IL-3) is overexpressed by T lymphocytes in multiple myeloma patients. Blood. 2006;107:841-2. (FC)
  6. 6. Janke M, Witsch EJ, Mages HW, Hutloff A, Kroczek RA. Eminent role of ICOS costimulation for T cells interacting with plasmacytoid dendritic cells. Immunology. 2006;118:353-60. (FC)
  7. 7. Andersson J, Abrams J, Björk L, Funa K, Litton M, Ågren K, et al. Concomitant in vivo production of 19 different cytokines in human tonsils. Immunology. 1994;83:16-24. (IHC-FS)
  8. 8. Ulfgren A, Lindblad S, Klareskog L, Andersson J, Andersson U. Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis. 1995;54:654-61. (IHC-FS)
See All References